A box full of viruses and bacteria has completed its return trip to the International **** e Station, and the changes these 'bugs' experienced in their travels could help us Earthlings tackle drug-resistant infections.
A team of researchers from the University of Wisconsin-Madison and US biotech company Rhodium Scientific Inc. pitted Escherichia coli bacteria against its viral arch-nemesis, the T7 bacteriophage. This pair has been locked in an evolutionary 'arms race' for as long as we've been looking, but never in microgravity – until they were sent to the ISS in 2020.
Related: The ISS Has
A team of researchers from the University of Wisconsin-Madison and US biotech company Rhodium Scientific Inc. pitted Escherichia coli bacteria against its viral arch-nemesis, the T7 bacteriophage. This pair has been locked in an evolutionary 'arms race' for as long as we've been looking, but never in microgravity – until they were sent to the ISS in 2020.
Related: The ISS Has
19 days ago